User contributions
This user is currently blocked. The latest block log entry is provided below for reference:
- 18:40, 26 January 2023 Davebridges (Talk | contribs) blocked Erinstephenson (Talk | contribs) with an expiry time of indefinite (account creation disabled)
- 20:39, 9 May 2016 (diff | hist) . . (+244) . . m Single fiber dissociation of intact rodent muscles (current)
- 20:34, 9 May 2016 (diff | hist) . . (+1,794) . . N Single fiber dissociation of intact rodent muscles (This protocol is for isolating single muscle fibers from intact mouse skeletal muscles. It is optimized for use with the Flexor Digitorum Brevis (superficial foot) muscle.)
- 15:38, 12 June 2015 (diff | hist) . . (+27) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 15:47, 10 March 2015 (diff | hist) . . (+45) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo (→NEFA determination from serum (use Wako Diagnostics NEFA-HR(2) Microtiter Kit))
- 15:44, 10 March 2015 (diff | hist) . . (-4) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo (→NEFA determination from serum (use Wako Diagnostics NEFA-HR(2) Microtiter Kit))
- 15:44, 10 March 2015 (diff | hist) . . (+449) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo (→NEFA determination from serum (use Wako Diagnostics NEFA-HR(2) Microtiter Kit))
- 15:21, 10 March 2015 (diff | hist) . . (+124) . . m Assessing isoproterenol-stimulated whole-body lipolysis in vivo (→Experimental protocol)
- 20:49, 19 February 2015 (diff | hist) . . (+16) . . Extraction of DNA from TRIZOL preparations
- 20:48, 19 February 2015 (diff | hist) . . (+93) . . Extraction of DNA from TRIZOL preparations (→Extraction steps)
- 20:46, 19 February 2015 (diff | hist) . . (+2,524) . . N Extraction of DNA from TRIZOL preparations (This protocol is for extracting DNA from TRIZOL preparations after the RNA-containing upper phase has been completely removed)
- 22:18, 13 October 2014 (diff | hist) . . (+1,289) . . N H&E Staining (Created page with "== Rehydrate tissue sections == #After cutting sections of tissue onto glass slides, de-pariffinize the tissue sections in xylene for 3 min. Repeat for a total of 3x 3 minute ...")
- 21:44, 22 September 2014 (diff | hist) . . (-4,100) . . Paraffin Embedding of Tissue Samples
- 21:52, 14 August 2014 (diff | hist) . . (+1,090) . . N How to design primer pairs for determining the presence of CrispR-cas induced mutations (Created page with "#Go to http://www.ncbi.nlm.nih.gov/nuccore/ and find the sequence of interest. #Scroll down to the sequence and highlight/copy the nucleotides corresponding with your CrispR ...") (current)
- 18:18, 24 July 2014 (diff | hist) . . (-2) . . m Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 18:17, 24 July 2014 (diff | hist) . . (-52) . . m Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 18:15, 24 July 2014 (diff | hist) . . (+70) . . m Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 18:13, 24 July 2014 (diff | hist) . . (-49) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 18:12, 24 July 2014 (diff | hist) . . (+498) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 17:28, 24 July 2014 (diff | hist) . . (+2,381) . . Assessing isoproterenol-stimulated whole-body lipolysis in vivo
- 14:48, 24 July 2014 (diff | hist) . . (+1,091) . . N Assessing isoproterenol-stimulated whole-body lipolysis in vivo (Created page with "== Assessing Isoproterenol-Stimulated Whole-Body Lipolysis ''in vivo'' == ##Note: Mice do not need to be in a fasted state prior to this test. #Briefly anesthetize mice with ...")
- 18:44, 22 July 2014 (diff | hist) . . (+509) . . Paraffin Embedding of Tissue Samples
- 18:24, 22 July 2014 (diff | hist) . . (+1,707) . . Paraffin Embedding of Tissue Samples
- 17:35, 17 February 2014 (diff | hist) . . (+80) . . m Rapamycin Injections
- 17:24, 17 February 2014 (diff | hist) . . (0) . . m Rapamycin Injections
